🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 3 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 24/08/1999 | 9,94 | 10,63 | 9,94 | 10,50 | +5,00% | 6,92% | 169.800 |
| 23/08/1999 | 10,44 | 10,50 | 10,00 | 10,00 | -3,61% | 4,79% | 44.800 |
| 20/08/1999 | 10,56 | 10,63 | 10,00 | 10,38 | +0,00% | 5,92% | 83.200 |
| 19/08/1999 | 11,25 | 11,25 | 9,88 | 10,38 | -8,79% | 12,22% | 346.600 |
| 18/08/1999 | 12,09 | 12,31 | 11,38 | 11,38 | -6,19% | 7,75% | 21.400 |
| 17/08/1999 | 11,63 | 12,31 | 11,56 | 12,13 | +4,30% | 6,45% | 106.400 |
| 16/08/1999 | 11,75 | 11,75 | 11,25 | 11,63 | +1,64% | 4,26% | 104.000 |
| 13/08/1999 | 11,50 | 11,63 | 11,38 | 11,44 | -0,54% | 2,17% | 47.000 |
| 12/08/1999 | 11,59 | 11,63 | 11,19 | 11,50 | +0,00% | 3,77% | 57.800 |
| 11/08/1999 | 10,75 | 12,00 | 10,63 | 11,50 | +7,60% | 12,79% | 156.800 |
| 10/08/1999 | 10,22 | 10,94 | 10,13 | 10,69 | +4,27% | 7,95% | 100.000 |
| 09/08/1999 | 9,91 | 10,38 | 9,91 | 10,25 | +3,80% | 4,73% | 112.800 |
| 06/08/1999 | 9,66 | 10,00 | 9,63 | 9,88 | +1,94% | 3,88% | 120.800 |
| 05/08/1999 | 10,06 | 10,06 | 9,56 | 9,69 | -2,52% | 4,97% | 260.000 |
| 04/08/1999 | 10,41 | 10,56 | 9,81 | 9,94 | -5,36% | 7,21% | 102.000 |
| 03/08/1999 | 10,50 | 10,75 | 10,31 | 10,50 | +3,07% | 4,17% | 177.200 |
| 02/08/1999 | 9,25 | 10,34 | 9,06 | 10,19 | +11,26% | 13,85% | 143.200 |
| 30/07/1999 | 9,00 | 9,16 | 8,69 | 9,16 | +5,40% | 5,21% | 173.400 |
| 29/07/1999 | 9,00 | 9,00 | 8,63 | 8,69 | -2,80% | 4,17% | 116.600 |
| 28/07/1999 | 8,69 | 9,25 | 8,66 | 8,94 | +4,38% | 6,83% | 123.600 |
| 27/07/1999 | 8,56 | 8,63 | 8,44 | 8,56 | -0,72% | 2,19% | 108.600 |
| 26/07/1999 | 8,61 | 8,66 | 8,56 | 8,63 | -0,36% | 1,09% | 74.400 |
| 23/07/1999 | 8,63 | 8,66 | 8,34 | 8,66 | +1,10% | 3,62% | 210.000 |
| 22/07/1999 | 8,44 | 8,63 | 8,44 | 8,56 | +0,74% | 2,22% | 186.200 |
| 21/07/1999 | 8,38 | 8,63 | 8,38 | 8,50 | +0,74% | 2,99% | 257.600 |
| 20/07/1999 | 8,56 | 8,56 | 8,31 | 8,44 | -0,74% | 2,92% | 235.400 |
| 19/07/1999 | 8,56 | 9,00 | 8,50 | 8,50 | +1,49% | 5,84% | 342.800 |
| 16/07/1999 | 8,31 | 8,63 | 7,75 | 8,38 | +0,75% | 10,53% | 137.600 |
| 15/07/1999 | 8,00 | 8,63 | 7,50 | 8,31 | +3,91% | 14,06% | 257.200 |
| 14/07/1999 | 7,75 | 8,25 | 7,50 | 8,00 | +4,92% | 9,68% | 477.600 |